SOPH
Sophia Genetics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 3
Bearish signal 2
Consensus Rating "Strong Buy"
Ample Liquidity
High Gross Profit Margin
EPS Below Expectations
Revenue Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About SOPH
Sophia Genetics Sa
A cloud-native software company in the healthcare space
Life Science Tools and Services
03/18/2011
07/23/2021
NASDAQ Stock Exchange
423
12-31
Common stock
La Pièce 12, CH-1180 Rolle, Switzerland
--
Sophia Genetics SA was incorporated in Switzerland on March 18, 2011. The company is a cloud-native software technology company in healthcare, dedicated to establishing data-driven medical practice as the standard of care and for life science research. The company purposefully built a cloud-native software platform capable of analyzing data and generating insights from complex multi-modal datasets and different diagnostic modes. The company's platform standardizes, calculates and analyzes digital health data and uses it in scattered locations to break down data silos.
Earnings Call
Q1/2025
Estimate EPS-0.19
Actual EPS-0.26
Estimate Revenue16.75M
Actual Revenue17.80M
SOPHiA Genetics Q1 2025: Unraveling Contradictions in Biopharma Revenue and Strategic Growth
May 10,2025 03:06
Earnings Decrypt
Earnings Decrypt
Q2/2025
Estimate EPS-0.17
Actual EPS-0.33
Estimate Revenue17.49M
Actual Revenue18.30M
SOPHiA GENETICS Q2 2025: Dissecting Contradictions in Biopharma Growth, ASPs, and Strategic Focus
Aug 05,2025 05:36
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
SOPH has released its 2025 Q3 earnings. EPS was reported at -0.3, versus the expected -0.2, missing expectations. The chart below visualizes how SOPH has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
SOPH has released its 2025 Q3 earnings report, with revenue of 19.46M, reflecting a YoY change of 22.77%, and net profit of -20.02M, showing a YoY change of -8.59%. The Sankey diagram below clearly presents SOPH's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
